A&R Consultants presenting “Cost Effective and Value-based Evidence Development” at the the 11th semi-annual Diagnostics Conference in Boston December 4-5th

Removing a Puzzle Piece

Cost effective & Value-based Evidence Development

Abstract: One of the more significant barriers to obtaining coverage and reimbursement for a new or established advanced diagnostic is the high cost of the evidence development establishing clinical relevance. Creative approaches and a multi-prong strategy are critical to successfully balance evidence development with budget limitations and internal/investor pressure to broadly launch commercially.

Topics presented to include:

  • Clearly defining and staying within intended use
  • From study to publication – value-based utility vs. traditional studies vs. value-based contracting
  • Advocacy through KOLs & relevant societies
  • Relevant patient-level appeals

Dx Reimbursement East